Get the Stockscreener App
0.9068
7.54%
-0.0739
After Hours:
.92
0.0132
+1.46%
Maxcyte Inc stock is traded at $0.9068, with a volume of 1.78M.
It is down -7.54% in the last 24 hours and down -41.87% over the past month.
MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and development. The company has developed and commercialized a proprietary Flow Electroporation platform, which facilitates the complex engineering of a wide variety of cells. The Company has one reportable segment, cell engineering technology. The revenue is generated from the sale and licensing of company's instruments, as well as sales of single-use disposable processing assemblies.
See More
Previous Close:
$0.9807
Open:
$0.99
24h Volume:
1.78M
Relative Volume:
1.80
Market Cap:
$96.73M
Revenue:
$45.44M
Net Income/Loss:
$-35.43M
P/E Ratio:
-2.6671
EPS:
-0.34
Net Cash Flow:
$-25.39M
1W Performance:
-21.83%
1M Performance:
-41.87%
6M Performance:
-57.02%
1Y Performance:
-80.24%
1-Day Range:
$0.8947
$0.995
1-Week Range:
$0.8947
$1.1849
52-Week Range:
$0.8947
$4.74
Maxcyte Inc Stock (MXCT) Company Profile
Name
Maxcyte Inc
Sector
Industry
Phone
301-517-5556
Address
9713 KEY WEST AVENUE,, ROCKVILLE
Compare MXCT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MXCT
Maxcyte Inc
|
0.9068 | 104.62M | 45.44M | -35.43M | -25.39M | -0.34 |
|
ABT
Abbott Laboratories
|
109.30 | 184.48B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
SYK
Stryker Corp
|
369.56 | 135.49B | 25.12B | 3.25B | 4.28B | 8.4018 |
|
BSX
Boston Scientific Corp
|
93.53 | 136.93B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
MDT
Medtronic Plc
|
102.96 | 129.48B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
81.36 | 47.29B | 5.88B | 1.34B | 799.60M | 2.3489 |
Maxcyte Inc Stock (MXCT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-11-25 | Downgrade | BTIG Research | Buy → Neutral |
| Aug-07-25 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jul-22-25 | Initiated | Stephens | Overweight |
| Nov-29-23 | Initiated | Craig Hallum | Buy |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Aug-24-21 | Initiated | BTIG Research | Buy |
| Aug-24-21 | Initiated | Cowen | Outperform |
| Aug-24-21 | Initiated | Stephens | Overweight |
| Aug-24-21 | Initiated | Stifel | Buy |
| Aug-24-21 | Initiated | Wedbush | Outperform |
| Aug-24-21 | Initiated | William Blair | Outperform |
View All
Maxcyte Inc Stock (MXCT) Latest News
Hedge Fund Moves: Will MaxCyte Inc outperform small cap indexes2025 Earnings Surprises & Reliable Intraday Trade Plans - baoquankhu1.vn
MaxCyte team building boosts morale at sales meeting - Traders Union
Aug Action: Is MaxCyte Inc showing insider buyingDip Buying & Reliable Price Breakout Signals - baoquankhu1.vn
IPO Launch: Is MaxCyte Inc showing insider buying2025 Historical Comparison & High Conviction Buy Zone Alerts - baoquankhu1.vn
Can MaxCyte Inc. disrupt its industryWeekly Loss Report & Daily Profit Maximizing Tips - mfd.ru
Hedge Fund Bets: Is Algoma Steel Group Inc benefiting from interest rate changesMarket Performance Recap & High Return Stock Watch Alerts - baoquankhu1.vn
Rally Mode: Is MaxCyte Inc showing insider buyingTrend Reversal & Safe Entry Zone Tips - baoquankhu1.vn
Dip Buying: Is INEO forming a breakout patternJuly 2025 Recap & Consistent Return Strategy Ideas - baoquankhu1.vn
Investor Mood: How interest rate cuts could boost MaxCyte Inc stockQuarterly Profit Report & Community Verified Trade Signals - Bộ Nội Vụ
MaxCyte to join the 2026 G-Rex Grant Tour in Houston - Traders Union
Published on: 2026-01-14 11:01:42 - baoquankhu1.vn
Day Trade: Is MaxCyte Inc stock affected by interest rate hikesOil Prices & Safe Entry Momentum Stock Tips - Bộ Nội Vụ
MaxCyte Announces Preliminary Unaudited Fourth Quarter and Full Year 2025 Financial Results - The Globe and Mail
MaxCyte announces preliminary unaudited fourth quarter and full year 2025 financial results - marketscreener.com
Maxcyte Announces Preliminary Unaudited Fourth Quarter And Full Year 2025 Financial Results - TradingView — Track All Markets
MaxCyte Announces Preliminary Unaudited Fourth Quarter and Full Year 2025 Financial Results - Benzinga
MaxCyte, Inc. (NASDAQ:MXCT) Receives Consensus Recommendation of “Hold” from Brokerages - Defense World
Risk Off: Can TriNet Group Inc. stock maintain growth trajectory2025 Technical Patterns & Fast Entry Momentum Trade Alerts - moha.gov.vn
Will MaxCyte Inc. stock rally after Fed decisionsStop Loss & Weekly Market Pulse Alerts - Улправда
MaxCyte (NASDAQ:MXCT) Stock Rating Lowered by Wall Street Zen - MarketBeat
MaxCyte® acquires SeQure Dx to broaden cell engineering offerings with on-target and off-target editing assessments - MSN
MaxCyte: Building the Future of Cell and Gene Therapy Innovation - MSN
How strong is MaxCyte Inc. stock balance sheet2025 Performance Recap & Community Driven Trade Alerts - Улправда
Is MaxCyte Inc. stock attractive after correctionTrail vs Road Selection & walk-ready comfort choices - ulpravda.ru
Will MaxCyte Inc. stock gain from government policiesTrade Volume Report & Entry and Exit Point Strategies - Улправда
Why MaxCyte Inc. stock remains undervaluedJuly 2025 Trends & Verified Short-Term Trading Plans - Улправда
Aug Outlook: Will MaxCyte Inc. stock gain from government policiesWeekly Trade Report & Risk Managed Investment Entry Signals - Улправда
How sustainable is MaxCyte Inc. stock dividend payout2025 Technical Patterns & Weekly Breakout Stock Alerts - Улправда
Will MaxCyte Inc. stock outperform value stocksWeekly Gains Report & Free Community Supported Trade Ideas - ulpravda.ru
Downgrade Watch: Why retail investors pile into MaxCyte Inc. stockQuarterly Profit Report & Accurate Buy Signal Notifications - ulpravda.ru
MaxCyte (NASDAQ:MXCT) Shares Up 0.7%Time to Buy? - MarketBeat
MaxCyte (NASDAQ:MXCT) Shares Up 0.7% – Time to Buy? - Defense World
Bear Alert: How strong is MaxCyte Inc stock balance sheet2025 Market Sentiment & Real-Time Volume Analysis - moha.gov.vn
Aug Patterns: Will MaxCyte Inc stock gain from government policiesInflation Watch & Safe Capital Growth Stock Tips - moha.gov.vn
MaxCyte, Inc.Common Stock (NQ: MXCT - FinancialContent
Will MaxCyte Inc. stock attract more institutional investorsBlue Chip Stock Analysis & Free Trading Psychology Coaching - Улправда
Will MaxCyte Inc. stock deliver strong dividend growth2026 world cup usa national team group stage defensive leaders pressing system tactical prediction guide - Улправда
MaxCyte eyes growth in cell engineering for 2026 - Traders Union
MXCT’s price-to-cash ratio: How it affects the stock’s valuation. - uspostnews.com
MaxCyte advances GMP process with KSQ partnership - Traders Union
Activity Recap: Why GIGGU stock appeals to dividend seekersTrade Entry Report & Smart Allocation Stock Reports - moha.gov.vn
Will MaxCyte Inc. stock benefit from sector rotationShare Buyback & Capital Efficient Trade Techniques - Улправда
Why retail investors pile into MaxCyte Inc. stock2025 Price Targets & Fast Entry Momentum Trade Alerts - Улправда
Is MaxCyte Inc. stock a bargain at current levels2025 Major Catalysts & Free Long-Term Investment Growth Plans - Улправда
Stock Recap: How buybacks impact MaxCyte Inc. stock valueJuly 2025 Summary & Verified Technical Trade Signals - DonanımHaber
MaxCyte, Inc.(NasdaqGS: MXCT) dropped from NASDAQ Biotechnology Index - marketscreener.com
MaxCyte, Inc. (NASDAQ:MXCT) Given Consensus Rating of "Hold" by Brokerages - MarketBeat
William Blair Downgrades MaxCyte (MXCT) - MSN
Prepare Yourself for Liftoff: MaxCyte Inc (MXCT) - setenews.com
Healthy Upside Potential: MaxCyte Inc (MXCT) - setenews.com
Mirabella Financial Services LLP Has $14.39 Million Stock Position in MaxCyte, Inc. $MXCT - MarketBeat
Maxcyte Inc Stock (MXCT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.28%
1.88%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):